April 28, 2025 Most Long COVID Cases Persist Beyond 2 Years In a three-year follow-up study, fewer than 2% of long COVID cases reported resolution of symptoms, with vaccinated patients demonstrating significantly better physical and mental health outcomes. Conexiant
April 29, 2025 AACR 2025: Oral HER2-Targeted Therapy for Advanced HER2-Mutated Lung Cancer The ASCO Post
April 29, 2025 AACR 2025: Oral HER2-Targeted Therapy for Advanced HER2-Mutated Lung Cancer The ASCO Post
April 28, 2025 AACR 2025: Zoldonrasib May Elicit Objective Responses in Patients With KRAS G12D–Mutated NSCLC The ASCO Post
July 12, 2023 Changing How Immune Checkpoint Inhibitors Are Delivered Could Reduce Costs by 14%, Study Finds The ASCO Post